NCT06465017 - ImmunoPET Targeting Trophoblast Cell-Surface Antigen 2 (Trop-2) in Thyroid Cancer | Biotech Hunter

Enrollment

120

Participants

Timeline

Start Date

January 12, 2024

Primary Completion Date

January 27, 2025

Study Completion Date

March 27, 2025

Conditions

TumorSolid TumorThyroid CancerPositron-Emission Tomography

Interventions

DIAGNOSTIC_TEST

standard-of-care imaging (18F-FDG and 68Ga-FAPI PET/CT), 68Ga-THP-Trop2 VHH PET/CT

Each subject receives a single intravenous injection of standard-of-care imaging radiopharmaceuticals (18F-FDG and 68Ga-FAPI) and 68Ga-THP-Trop2 VHH, and undergoes PET/CT imaging within the specified time.

Trial Locations (1)

361003

The First Affiliated Hospital of Xiamen University, Xiamen

All Listed Sponsors

lead

The First Affiliated Hospital of Xiamen University

OTHER